Journal of Dairy Science
Volume 90, Issue 6 , Pages 2630-2640 , June 2007

Effect of Bifidobacterium bifidum Fermented Milk on Helicobacter pylori and Serum Pepsinogen Levels in Humans

  • K. Miki

      Affiliations

    • Faculty of Medicine, Toho University, Ota-ku,Tokyo 143-8540, Japan
    • ,
  • Y. Urita

      Affiliations

    • Faculty of Medicine, Toho University, Ota-ku,Tokyo 143-8540, Japan
    • ,
  • F. Ishikawa

      Affiliations

    • Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo 186-8650, Japan
    • Corresponding Author InformationCorresponding author.
    • ,
  • T. Iino

      Affiliations

    • Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo 186-8650, Japan
    • ,
  • H. Shibahara-Sone

      Affiliations

    • Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo 186-8650, Japan
    • ,
  • R. Akahoshi

      Affiliations

    • Faculty of Research and Development, Yakult Honsha, Shimbashi, Tokyo 105-8660, Japan
    • ,
  • S. Mizusawa

      Affiliations

    • Faculty of Research and Development, Yakult Honsha, Shimbashi, Tokyo 105-8660, Japan
    • ,
  • A. Nose

      Affiliations

    • Faculty of Research and Development, Yakult Honsha, Shimbashi, Tokyo 105-8660, Japan
    • ,
  • D. Nozaki

      Affiliations

    • Faculty of Research and Development, Yakult Honsha, Shimbashi, Tokyo 105-8660, Japan
    • ,
  • K. Hirano

      Affiliations

    • Faculty of Research and Development, Yakult Honsha, Shimbashi, Tokyo 105-8660, Japan
    • ,
  • C. Nonaka

      Affiliations

    • Faculty of Research and Development, Yakult Honsha, Shimbashi, Tokyo 105-8660, Japan
    • ,
  • T. Yokokura

      Affiliations

    • Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo 186-8650, Japan

Received 1 December 2006 ,Accepted 1 February 2007.

References 

  1. Asahara T, Shimizu K, Ohashi Y, Matsuki T, Matsumoto K, Takada T, et al. The effects of bifidobacteria-fermented milk on human urinary mutagenicity, which increases following ingestion of cooked ground beef. J. Intest. Microbiol. 1999;12:89–96(in Japanese)
  2. Asaka M, Kimura T, Kudo M, Terada H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–766
  3. Coconnier MH, Lievin V, Hermery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 1998;64:4373–4380
  4. Colin-Jones DG A working party. Management of dyspepsia: Report of a working party. Lancet. 1988;I:576–579
  5. Collado MC, González A, González R, Hernández M, Ferrús MA, Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int. J. Antimicrob. Agents. Food Microbiol. 2005;25:385–391
  6. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J. Clin. Pathol. 1994;47:61–66
  7. Cruchet S, Obregon MC, Salazar G, Diaz E, Gottenland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition. 2003;19:716–721
  8. de Vrese M, Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br. J. Nutr. 2002;88(Suppl):S59–S66
  9. di Mario F, Moussa AM, Cavallaro LG, Caruana P, Merli R, Bertolini S, et al. Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Digestion. 2004;70:167–172
  10. Felley CP, Corthésy-Theulaz I, Rivero J-LB, Sipponen P, Kaufmann M, Bauerfeind P, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol. 2001;13:25–29
  11. Freshney R. Culture of Animal Cells. A Manual of Basic Technique. New York, NY: Alan R. Liss Inc.; 1987;Page 117
  12. Fuller R. Probiotics in human medicine. Gut. 1991;32:439–442
  13. Hamada H, Haruma K, Mihara M, Kameda T, Yoshihara M, Sumii K, et al. High incidence of reflux oesphagitis after eradication therapy for Helicobacter pylori: Impacts of hiatal hernia and corpus gastritis. Aliment. Pharmacol. Ther. 2000;14:729–735
  14. Hamilton-Miller JMT. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents. 2003;22:360–366
  15. Haruma K, Mihara M, Okamoto E, Kusunoki H, Hananlki M, Tanaka S, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—Evaluation of 24-h pH monitoring. Aliment. Pharmacol. Ther. 1999;13:155–162
  16. Hunter FM, Correa P, Fontham E, Ruiz B, Sobhan M, Samloff IM. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig. Dis. Sci. 1993;38:2081–2086
  17. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am. J. Gastroenterol. 1996;91:959–962
  18. Kiyohira K, Yoshihara M, Ito M, Hamura K, Tanaka S, Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J. Gastroenterol. 2003;38:332–338
  19. Knight T, Greaves S, Wilson A, Hengels K, Newell D, Corlett M, et al. Variability in serum pepsinogen levels in an asymptomatic population. Eur. J. Gastroenterol. Hepatol. 1995;7:647–654
  20. Kobayashi D, Eishi Y, Ohkusa T, Ishige I, Suzuki T, Minami J, et al. Gastric mucosal density of Helicobacter pylori estimated by real-time PCR compared with results of urea breath test and histological grading. J. Med. Microbiol. 2002;51:305–311
  21. Kuiphers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345:1525–1528
  22. Lind T, Megraud F, Unge P, Bayerdorffer E, O’Morain C, Spiller R, et al. The MACH 2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology. 1999;116:248–253
  23. Linsalata M, Russo F, Berloco P, Caruso ML, Matteo GD, Cifone MG, et al. The influence of Lactobacillus brevis on ornitine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter. 2004;9:165–172
  24. Lopes AI, Palha A, Lopes T, Monteiro L, Oleastro M, Fernandes A. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population. Scand. J. Gastroenterol. 2006;41:524–531
  25. Malfertheiner P, Mégraud F, O’Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection—The Maastricht 2—2000 Consensus report. Aliment. Pharmacol. Ther. 2002;16:167–180
  26. Mascitelli L, Pezzetta F. Quadruple treatments for Helicobacter pylori. Lancet. 2003;361:86
  27. Matsumoto S, Washizuka Y, Matsumoto Y, Tawara S, Ikeda F, Yokota Y, et al. Appearance of metronidazole-resistant Helicobacter pylori strain in an infected ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains. Antimicrob. Agents Chemother. 1997;41:2602–2605
  28. McKay LF, Holbrook WP, Eastwood MA. Methane and hydrogen production by human intestinal anaerobic bacteria. Acta Pathol. Microbiol. Immunol. Scand. Sect. B. 1982;90:257–260
  29. Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol. 1995;79:475–479
  30. Miki K. Pepsinogen Test Method Handbook. Tokyo, Japan: Medical View Inc.; 2001;
  31. Miki K, Ichinose M, Ishikawa KB, Yanagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn. J. Cancer Res. 1993;84:1086–1090
  32. Miki K, Ishinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol. Jpn. 1987;22:133–141
  33. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am. J. Gastroenterol. 2003;98:735–739
  34. Morris A, Nicholson G. Infection of Campylobacter pylori causes gastritis and raised fasting gastric pH. Am. J. Gastroenterol. 1987;82:192–199
  35. Nagaoka M, Hashimoto S, Watanabe T, Yokokura T, Mori Y. Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides. Biol. Pharm. Bull. 1994;17:1012–1017
  36. Nozoe M, Nishida M, Todoroki T, Iwasaki Y. Establishment and characterization of a human scirrhus type gastric cancer cell line, GCIY, producing CA19-9. Hum. Cell. 1991;4:71–75
  37. Oderda G. Results of data collected by the Paediatric European Register for treatment of Helicobacter pylori (PERTH). Helicobacter. 2003;8:452
  38. Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, et al. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: Comparison with H. pylori-negative patients. Aliment. Pharmacol. Ther. 2004;20(Suppl. 1):25–32
  39. Olson JW, Maier RJ. Molecular hydrogen as an energy source for Helicobacter pylori. Science. 2002;298:1788–1790
  40. Pantoflickova D, Corthésy-Theulaz I, Dorta G, Stolte M, Isler P, Rochat F, et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori-associated gastritis. Aliment. Pharmacol. Ther. 2003;18:805–813
  41. Perri F, Clemente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, et al. The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand. J. Clin. Lab. Invest. 1998;58:19–27
  42. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988;94:33–40
  43. Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobaccilus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 2001;47:709–710
  44. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterol. 1982;83:204–209
  45. Sgouras D, Maragkoudakis P, Petraka K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 2004;70:518–526
  46. Sgouras D, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A. Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin. Diagn. Lab. Immunol. 2005;12:1378–1386
  47. Shimakawa Y, Matsubara S, Yuki N, Ikeda M, Ishikawa F. Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. Intern. J. Food Microbiol. 2003;81:131–136
  48. Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. J. Gastroenterol. Hepatol. 2005;20:1652–1660
  49. Tamura A, Kumai H, Nakamura N, Nakamichi T, Sugiyama T, Deguchi R, et al. Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain. J. Gastroenterol. Hepatol. 2006;21:1399–1406
  50. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarks Prev. 1997;6:639–642
  51. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001;345:784–789
  52. Urita Y, Ishihara S, Akimoto T, Kato H, Hara N, Honda Y, et al. Hydrogen and methane gases are frequently detected in the stomach. World J. Gastroenterol. 2006;12:3088–3091
  53. Wagner S, Haruma K, Gladziwa U, Soudah B, Gebel M, Bleck J, et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: Significance of inflammation and effect of bacterial eradication. Am. J. Gastroenterol. 1994;89:1211–1218
  54. Wang K-Y, Li S-N, Liu C-S, Perng D-S, Su Y-C, Wu D-C, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr. 2004;80:737–741
  55. Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: Non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand. J. Gastroenterol. 2006;41:149–154
  56. Yamamoto Y, Sakurabayasi S, Abe K, Sezai S, Hirano M, Oka H. Anti-ulcer effect of Bifidobacterium bifidum YIT 4007. Jpn. Pharmacol. Ther. 1994;22:4743–4746(in Japanese)
  57. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997;41:442–451
  58. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, et al. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut. 1998;42:609–617
  59. Yildirim Z, Johnson MG. Characterization and antimictobial spectrum of Bifidicin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. J. Food Prot. 1998;61:47–51
  60. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am. J. Gastroenterol. 1998;93:1090–1096

PII: S0022-0302(07)70074-7

doi: 10.3168/jds.2006-803

Journal of Dairy Science
Volume 90, Issue 6 , Pages 2630-2640 , June 2007

Article Tools

* Image Usage & Resolution